Dr. Sulaiman Al Habib Medical Services Group Company Share Price

Equities

4013

SA1510P1UMH1

Healthcare Facilities & Services

Market Closed - Saudi Arabian S.E. 12:58:13 13/06/2024 BST 5-day change 1st Jan Change
293.2 SAR -0.20% Intraday chart for Dr. Sulaiman Al Habib Medical Services Group Company -0.20% +3.24%

Financials

Sales 2024 * 11.33B 3.02B 238B Sales 2025 * 14.42B 3.85B 303B Capitalization 101B 26.89B 2,117B
Net income 2024 * 2.2B 587M 46.23B Net income 2025 * 2.73B 729M 57.36B EV / Sales 2024 * 9.41 x
Net Debt 2024 * 5.89B 1.57B 124B Net Debt 2025 * 5.97B 1.59B 125B EV / Sales 2025 * 7.41 x
P/E ratio 2024 *
45.8 x
P/E ratio 2025 *
37.7 x
Employees -
Yield 2024 *
1.53%
Yield 2025 *
1.72%
Free-Float 31.2%
More Fundamentals * Assessed data
Dynamic Chart
Dr. Sulaiman Al Habib Medical Services Secures Final License for Hospital Operations in Saudi Arabia MT
Dr. Sulaiman Al Habib Medical Services Declares Q1 Dividend MT
Dr. Sulaiman Al Habib Medical Services Group Company Announces Cash Dividend for First Quarter of the Fiscal Year 2024, Payable on June 10, 2024 CI
Dr. Sulaiman Al Habib Medical Services Group Company Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Dr. Sulaiman Al Habib Medical Services Logs Increase in Q1 Profit, Revenue MT
Alandalus Property, Dr. Sulaiman Al Habib Medical Services Receive Saudi License for Hospital Operations MT
Dr. Sulaiman Al Habib Medical Services Group Company Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Alandalus Property Co. Updates on the Latest Developments Related to the Company's Joint Venture with Dr. Sulaiman Al Habib Medical Services Group in Jeddah CI
Dr. Sulaiman Al Habib Medical Services Group Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Saudi Arabia healthcare group Fakeeh Care weighs IPO, appoints HSBC - sources RE
Dr. Sulaiman Al Habib Medical Services Group Company Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Saudi bourse gains, Dubai extends losses ahead of U.S. debt-limit talks RE
Dr. Sulaiman Al Habib Medical Services Group Company Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Dr. Sulaiman Al Habib Medical Services Group Company Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Dr. Sulaiman Al Habib Medical Services Group Company Approves Resignation of Nasser Mohammed Abdulaziz Al-Huqbani as Non-Executive Board Member, effective 15 February 2023 CI
More news
1 day-0.20%
1 week-0.20%
Current month+9.32%
1 month-1.28%
3 months-9.11%
6 months+7.09%
Current year+3.24%
More quotes
1 month
267.80
Extreme 267.8
312.00
Current year
267.80
Extreme 267.8
346.80
1 year
223.20
Extreme 223.2
346.80
3 years
148.00
Extreme 148
346.80
5 years
52.50
Extreme 52.5
346.80
10 years
52.50
Extreme 52.5
346.80
More quotes
Managers TitleAgeSince
Chief Executive Officer - 21/10/11
Founder - 31/12/94
Chief Tech/Sci/R&D Officer - 31/12/06
Members of the board TitleAgeSince
Director/Board Member 58 09/12/21
Director/Board Member - 09/12/21
Director/Board Member - 31/12/14
More insiders
Date Price Change Volume
13/06/24 288 -1.97% 451,328
12/06/24 293.8 -2.72% 235,709
11/06/24 302 -2.20% 411,411

Delayed Quote Saudi Arabian S.E., June 13, 2024 at 12:58 pm

More quotes
Dr. Sulaiman Al-Habib Medical Services Group Company is a Saudi Arabia-based company engaged in health care sector. The Company operates through it's subsidiaries in three segments: Hospitals, Pharmacies and Other. The Hospital segment is engaged in setting up, managing and operating hospitals, medical facilities, pharmacies and medical diagnostic and radiological laboratories. The Pharmacies segment operates Al Habib Pharmacies, Middle East Pharmacies Company and Afia Pharmacies Company. The Other segments include management and operations services for third party, home healthcare service, intensive care units, ambulatory transportation, facility maintenance services information technology and systems services, cloud solutions, among others. The Company also provides import and export, wholesale and retail sale of medicines, medical and herbal products, cosmetics, medical devices and equipment.
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
288 SAR
Average target price
291.1 SAR
Spread / Average Target
+1.08%
Consensus